FDA Grants Approval for I-Flow Kit
<i> Dow Jones</i>
I-Flow Corp. said Tuesday it received approval from the U.S. Food and Drug Administration to market its disposable PainBuster infusion pain management kit for orthopedic surgery patients.
I-Flow said the system uses Bupivacaine HC1, a nonnarcotic drug, avoiding the side effects of narcotics like morphine. The drug is infused directly into a patient 24 to 48 hours after an operation,
The Lake Forest company’s stock climbed 13%, or 25 cents, to $2.13 a share.
I-Flow designs medical infusion systems for inpatient and outpatient care.
